PortfoliosLab logo
WES vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between WES and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.4

Performance

WES vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Western Midstream Partners, LP (WES) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

200.00%400.00%600.00%800.00%1,000.00%December2025FebruaryMarchAprilMay
152.82%
834.89%
WES
ABBV

Key characteristics

Sharpe Ratio

WES:

0.51

ABBV:

0.98

Sortino Ratio

WES:

0.85

ABBV:

1.35

Omega Ratio

WES:

1.10

ABBV:

1.21

Calmar Ratio

WES:

0.83

ABBV:

1.28

Martin Ratio

WES:

2.23

ABBV:

3.19

Ulcer Index

WES:

6.23%

ABBV:

8.31%

Daily Std Dev

WES:

27.30%

ABBV:

27.09%

Max Drawdown

WES:

-93.66%

ABBV:

-45.09%

Current Drawdown

WES:

-13.45%

ABBV:

-7.55%

Fundamentals

Market Cap

WES:

$13.85B

ABBV:

$342.01B

EPS

WES:

$4.02

ABBV:

$2.34

PE Ratio

WES:

9.04

ABBV:

82.62

PEG Ratio

WES:

5.48

ABBV:

0.42

PS Ratio

WES:

3.98

ABBV:

6.12

PB Ratio

WES:

4.51

ABBV:

105.59

Total Revenue (TTM)

WES:

$2.72B

ABBV:

$57.37B

Gross Profit (TTM)

WES:

$1.78B

ABBV:

$44.44B

EBITDA (TTM)

WES:

$1.72B

ABBV:

$16.33B

Returns By Period

In the year-to-date period, WES achieves a -3.41% return, which is significantly lower than ABBV's 13.78% return. Over the past 10 years, WES has underperformed ABBV with an annualized return of 1.79%, while ABBV has yielded a comparatively higher 16.81% annualized return.


WES

YTD

-3.41%

1M

-9.63%

6M

1.17%

1Y

9.29%

5Y*

47.93%

10Y*

1.79%

ABBV

YTD

13.78%

1M

-0.66%

6M

-0.67%

1Y

25.58%

5Y*

24.46%

10Y*

16.81%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

WES vs. ABBV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WES
The Risk-Adjusted Performance Rank of WES is 6868
Overall Rank
The Sharpe Ratio Rank of WES is 6969
Sharpe Ratio Rank
The Sortino Ratio Rank of WES is 6060
Sortino Ratio Rank
The Omega Ratio Rank of WES is 5858
Omega Ratio Rank
The Calmar Ratio Rank of WES is 8080
Calmar Ratio Rank
The Martin Ratio Rank of WES is 7373
Martin Ratio Rank

ABBV
The Risk-Adjusted Performance Rank of ABBV is 8080
Overall Rank
The Sharpe Ratio Rank of ABBV is 8282
Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 7373
Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 7777
Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 8787
Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 7979
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

WES vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Western Midstream Partners, LP (WES) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for WES, currently valued at 0.51, compared to the broader market-2.00-1.000.001.002.003.00
WES: 0.51
ABBV: 0.98
The chart of Sortino ratio for WES, currently valued at 0.85, compared to the broader market-6.00-4.00-2.000.002.004.00
WES: 0.85
ABBV: 1.35
The chart of Omega ratio for WES, currently valued at 1.10, compared to the broader market0.501.001.502.00
WES: 1.10
ABBV: 1.21
The chart of Calmar ratio for WES, currently valued at 0.83, compared to the broader market0.001.002.003.004.005.00
WES: 0.83
ABBV: 1.28
The chart of Martin ratio for WES, currently valued at 2.23, compared to the broader market-40.00-30.00-20.00-10.000.0010.0020.00
WES: 2.23
ABBV: 3.19

The current WES Sharpe Ratio is 0.51, which is lower than the ABBV Sharpe Ratio of 0.98. The chart below compares the historical Sharpe Ratios of WES and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.002.50December2025FebruaryMarchAprilMay
0.51
0.98
WES
ABBV

Dividends

WES vs. ABBV - Dividend Comparison

WES's dividend yield for the trailing twelve months is around 7.23%, more than ABBV's 3.21% yield.


TTM20242023202220212020201920182017201620152014
WES
Western Midstream Partners, LP
7.23%8.33%8.52%6.80%5.69%11.25%12.45%8.28%5.44%4.04%3.86%1.73%
ABBV
AbbVie Inc.
3.21%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%

Drawdowns

WES vs. ABBV - Drawdown Comparison

The maximum WES drawdown since its inception was -93.66%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for WES and ABBV. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%December2025FebruaryMarchAprilMay
-13.45%
-7.55%
WES
ABBV

Volatility

WES vs. ABBV - Volatility Comparison

Western Midstream Partners, LP (WES) and AbbVie Inc. (ABBV) have volatilities of 14.01% and 13.36%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%16.00%December2025FebruaryMarchAprilMay
14.01%
13.36%
WES
ABBV

Financials

WES vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Western Midstream Partners, LP and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20212022202320242025
928.50M
13.34B
(WES) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items

WES vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Western Midstream Partners, LP and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%55.0%60.0%65.0%70.0%75.0%80.0%85.0%20212022202320242025
75.1%
83.9%
(WES) Gross Margin
(ABBV) Gross Margin
WES - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Western Midstream Partners, LP reported a gross profit of 697.26M and revenue of 928.50M. Therefore, the gross margin over that period was 75.1%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
WES - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Western Midstream Partners, LP reported an operating income of 425.74M and revenue of 928.50M, resulting in an operating margin of 45.9%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
WES - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Western Midstream Partners, LP reported a net income of 333.61M and revenue of 928.50M, resulting in a net margin of 35.9%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.